Results 141 to 150 of about 440,113 (381)
Differential Inflammatory Responses in Cultured Endothelial Cells Exposed to Two Conjugated Linoleic Acids (CLAs) under a Pro-Inflammatory Condition [PDF]
Carina Valenzuela +3 more
openalex +1 more source
Revisiting Asset Pricing Models: The Case for an Intangibles Factor
ABSTRACT In an increasingly knowledge‐based economy, intangible assets may be an important driver of firm performance and stock returns. We introduce an intangibles intensity factor (INT), distinct from the organization capital factor, and show that exposure to this factor strongly predicts stock returns, outperforming traditional factors.
Dion Bongaerts +2 more
wiley +1 more source
Recent N∗ results from photoproduction experiments at CLAS [PDF]
D. Sokhan +7 more
openalex +1 more source
Dermatologic Features of Endocrine Tumor Syndromes—Systematic Review and Meta‐Analysis
ABSTRACT Endocrine tumor syndromes, including multiple endocrine neoplasia types 1, 2A, and 2B (MEN1, MEN2A, MEN2B), Carney complex (CNC), and PTEN hamartoma tumor syndrome (PHTS), are hereditary conditions characterized by multisystem tumor development.
Sára Pálla +8 more
wiley +1 more source
RESUMO Avaliou-se o efeito da adição do ácido linoleico conjugado (CLA) ao meio de cultivo in vitro na viabilidade pós-vitrificação de embriões F1 Holandês x Zebu.
A.C. Leite +3 more
doaj +1 more source
Effect of Extruded Cotton Seed and Canola Seed on Carcass Traits and CLA Content of Longissimus Dorsi Muscle in Mehraban Lambs [PDF]
Morteza Hosseini Ghaffari +2 more
openalex +1 more source
Cost‐utility of LBBAP CRT versus BVP CRT. ABSTRACT Introduction Cardiac resynchronization therapy (CRT) is a well‐established treatment for patients with heart failure (HF). Recently, left bundle branch area pacing (LBBAP) has emerged as a more physiological alternative to biventricular pacing (BVP) for CRT.
José M. Sánchez‐Moreno +8 more
wiley +1 more source
Litifilimab efficacy on skin outcomes in cutaneous lupus erythematosus in the Phase 2 LILAC study
Our findings show that greater proportions of litifilimab‐treated participants than placebo experienced 20%, 50%, 70% or 90% improvements in CLASI‐A score from baseline and CLASI‐A scores of 0–1 or 0–3. Similar results were observed using physician global assessments, supporting the Phase 2 LILAC study primary analysis in CLE.
Victoria P. Werth +8 more
wiley +1 more source
Clas-Maze: An Edutainment Tool Combining Tangible Programming and Living Knowledge
Xing Qian +3 more
openalex +2 more sources

